ArticleCell research2024

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.

Xinjing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.